Daniel R. Chard's most recent trade in Medifast Inc was a trade of 36,968 Common Stock done . Disclosure was reported to the exchange on March 13, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2026 | 36,968 | 183,406 (1%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.59 per share. | 13 Mar 2026 | 20,095 | 146,438 (1%) | 0% | 9.6 | 192,711 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 10.11 per share. | 13 Mar 2026 | 17,678 | 17,678 (0%) | 0% | 10.1 | 178,725 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.62 per share. | 13 Mar 2026 | 7,075 | 169,171 (1%) | 0% | 9.6 | 68,062 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2026 | 4,827 | 188,233 (1%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.05 per share. | 13 Mar 2026 | 2,638 | 166,533 (1%) | 0% | 10.1 | 26,512 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 13.13 per share. | 13 Jun 2025 | 381 | 149,698 (1%) | 0% | 13.1 | 5,003 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 124,953 | 176,246 (1%) | 1% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.87 per share. | 13 Mar 2025 | 5,001 | 54,101 (0%) | 0% | 13.9 | 69,364 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.35 per share. | 13 Mar 2025 | 1,864 | 51,293 (0%) | 0% | 14.3 | 26,748 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.94 per share. | 13 Mar 2025 | 944 | 53,157 (0%) | 0% | 13.9 | 13,159 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 149,317 | 149,317 (1%) | 1% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 149,317 | 0 (0%) | 1% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 108,598 | 108,598 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 108,598 | 0 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 40,719 | 149,317 (1%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 40,719 | 59,102 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.61 per share. | 15 Mar 2024 | 1,859 | 99,821 (0%) | 0% | 36.6 | 68,058 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.61 per share. | 15 Mar 2024 | 942 | 101,680 (0%) | 0% | 36.6 | 34,487 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.61 per share. | 15 Mar 2024 | 608 | 102,622 (0%) | 0% | 36.6 | 22,259 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 45,087 | 103,230 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Chard Daniel R. | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 16,486 | 63,614 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | R. Chard Daniel | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.68 per share. | 14 Feb 2024 | 5,471 | 58,143 (0%) | 0% | 52.7 | 288,212 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 34,076 | 48,194 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 16,807 | 47,128 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 109.99 per share. | 24 Feb 2023 | 15,643 | 32,551 (0%) | 0% | 110.0 | 1,720,574 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.46 per share. | 24 Feb 2023 | 1,358 | 31,193 (0%) | 0% | 104.5 | 141,857 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.75 per share. | 24 Feb 2023 | 872 | 30,321 (0%) | 0% | 102.8 | 89,598 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.31 per share. | 21 Feb 2023 | 1,815 | 14,118 (0%) | 0% | 115.3 | 209,288 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 183.28 per share. | 05 May 2022 | 431 | 108,598 (0%) | 0% | 183.3 | 78,995 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 8,509 | 21,139 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 180.52 per share. | 16 Mar 2022 | 878 | 20,261 (0%) | 0% | 180.5 | 158,497 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.06 per share. | 22 Feb 2022 | 1,804 | 13,912 (0%) | 0% | 177.1 | 319,416 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.06 per share. | 22 Feb 2022 | 1,282 | 12,630 (0%) | 0% | 177.1 | 226,991 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2022 | 3,375 | 16,886 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2022 | 3,375 | 107,214 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2022 | 953 | 15,933 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2022 | 953 | 108,167 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 186.47 per share. | 04 Feb 2022 | 690 | 103,839 (0%) | 0% | 186.5 | 128,667 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2021 | 90,610 | 15,716 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2021 | 90,610 | 90,610 (0%) | 0% | 0 | Common Stock |